,,ib ,union ,calendar ,no4 #dcd #aadth ,,congress #b;d ,session ,h4 ,r4 #dihb ,report ,no4 #aad-efj ,,in ,,the ,,house ,,of ,,representatives ,april #ah1 #bjaf ,mr4 ,foster 7for himself and ,mr4 ,pallone7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,may #aj1 #bjaf;,additional sponsors3 ,ms4 ,herrera ,beutler1 ,mr4 ,rokita1 ,mr4 ,kilmer1 and ,mr4 ,turner ,may #aj1 #bjaf ,reported with an amendment1 committed to the ,committee of the ,whole ,house on the ,state of the ,union1 and ordered to be printed ,strike out all after the enacting clause and insert the part printed in italic ,for text of introduced bill1 see copy of bill as introduced on ,april #ah1 #bjaf ,a ,,bill ,to direct the ,comptroller ,general of the ,united ,states to evaluate and report on the in-patient and outpatient treatment capacity1 availability1 and needs of the ,united ,states4 #a4 ,short title ,this ,act may be cited as the ,examining ,opioid ,treatment ,infrastructure ,act of #bjaf4 #b4 ,study on treatment infrastructure ,not later than #bd months after the date of enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall initiate an evaluation1 and submit to ,congress a report1 of the inpatient and outpatient treatment capacity1 availability1 and needs of the ,united ,states1 which shall include1 to the extent data are available-- 7#a7 the capacity of acute residential or inpatient detoxification programs2 7#b7 the capacity of inpatient clinical stabilization programs1 transitional residential support services1 and residential rehabilitation programs2 7#c7 the capacity of demographic specific residential or inpatient treatment programs1 such as those designed for pregnant women or adolescents2 7#d7 geographical differences of the availability of residential and outpatient treatment and recovery options for substance use disorders across the continuum of care2 7#e7 the availability of residential and outpatient treatment programs that offer treatment options based on reliable scientific evidence of efficacy for the treatment of substance use disorders1 including the use of ,food and ,drug ,administration-approved medicines and evidence-based nonpharmacological therapies2 7#f7 the number of patients in residential and specialty outpatient treatment services for substance use disorders2 7#g7 an assessment of the need for residential and outpatient treatment for substance use disorders across the continuum of care2 7#h7 the availability of residential and outpatient treatment programs to ,american ,indians and ,alaska ,natives through an ,indian health program 7as defined by section #d of the ,indian ,health ,care ,improvement ,act 7#be ,u4,s4,c4 #afjc772 and 7#i7 the barriers 7including technological barriers7 at the ,federal1 ,state1 and local levels to real-time reporting of de-identified information on drug overdoses and ways to overcome such barriers4 ,may #aj1 #bjaf ,reported with an amendment1 committed to the ,committee of the ,whole ,house on the ,state of the ,union1 and ordered to be printed